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ern MJ. Attenuated Coronary Collateral Function After Drug-Eluting Stent Implantation (editorial comment). J Am
oll Cardiol 2007;49:21–2.
he following section should have been stated as follows. The author apologizes for this error.
hy would the drugs on DES have an influence on collateral function? Sirolimus (Rapamycin) and Taxol (Paclitaxel)
re both potent immunosuppressant and antiproliferative drugs. Paclitaxel binds to cellular microtubules inhibiting the
epolymerization into tubulin, blocking cellular mitosis and proliferation. Sirolimus acts by binding to the cytosolic protein
K-binding protein 12 (FKBP12). The sirolimus-FKBP12 complex does not effect calcineurin but rather inhibits the
ammalian target of rapamycin (mTOR) pathway through derepression of PP2A, inhibiting lymphocyte proliferation, and
esponses to IL-2 as well as blocking the activation of T- and B-cells. Some of these mechanisms likely impact either the
timuli to or direct response of collateral angiogenesis (6,10).
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